Text Size

Registry of Pediatric Patients Diagnosed With Crohn's Disease in Belgium (Belcro)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition
ClinicalTrials.gov Identifier:
NCT01241058
First received: November 15, 2010
Last updated: NA
Last verified: November 2010
History: No changes posted
  Purpose

A registry of pediatric patients (under 18 yrs of age) diagnosed with Crohn's disease was created in Belgium. Over a 2 year period 257 patients are included. These patients will be follow up prospectively during 5 years. Demographic data, family history, disease presentation and disease course including medication are registered in CRF's.


Condition
Description of Disease Course, Disease Fenotype, Medication, Safety, Analysis for Possible Associations

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Belgian Registry of Pediatric Crohn's Disease

Resource links provided by NLM:

MedlinePlus related topics: Crohn's Disease
U.S. FDA Resources

Further study details as provided by Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition:

Primary Outcome Measures:
  • disease course [ Time Frame: 5 years ] [ Designated as safety issue: No ]
    describe patient characteristics, disease fenotype and course


Enrollment: 257
Study Start Date: May 2008
Estimated Study Completion Date: April 2015
Estimated Primary Completion Date: April 2015 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   1 Year to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

subjects under 18 yrs of age diagnosed with Crohn's disease, living in Belgium

Criteria

Inclusion Criteria:

1-18 yrs old belgian Crohn s disease informed consent

Exclusion Criteria:

no informed consent

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01241058

Locations
Belgium
Bespghan
Leuven, Brabant, Belgium, 3000
Sponsors and Collaborators
Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition
  More Information

No publications provided

Responsible Party: Gigi Veereman, Bespghan
ClinicalTrials.gov Identifier: NCT01241058     History of Changes
Other Study ID Numbers: Bespghan
Study First Received: November 15, 2010
Last Updated: November 15, 2010
Health Authority: Belgium: Institutional Review Board

Keywords provided by Belgian Society for Pediatric Gastroentrology Hepatology and Nutrition:
pediatrics, crohn's disease, disease course, therapy

Additional relevant MeSH terms:
Crohn Disease
Disease Progression
Inflammatory Bowel Diseases
Gastroenteritis
Gastrointestinal Diseases
 Digestive System Diseases
Intestinal Diseases
Disease Attributes
Pathologic Processes

ClinicalTrials.gov processed this record on May 23, 2013